Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Experts point out the broader structure of the market continues to remain weak as Nifty is making a lower top and lower bottom formation.
The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.
There's no relief from the COVID-19 front as the numbers are not showing any signs of slowing down yet and that could result in further extension of the lockdown, said Ajit Mishra of Religare Broking.
It needs to be seen if we can cross the medium-term resistance of 9,350. This would mean a lot for the markets.
Bank Nifty has been a laggard in the current up move and it should witness a strong up move as it has crossed its 20-day short term average after two months.
Mitessh Thakkar of mitesshthakkar.com recommends buying Apollo Hospitals with a stop loss of Rs 1,174, target at Rs 1,235 and CESC with a stop loss of Rs 412, target at Rs 450.
Ashwani Gujral of ashwanigujral.com suggests buying Sun Pharma with a stop loss of Rs 388, target of Rs 404 and Cipla with a stop loss of Rs 420, target of Rs 435.
Gujarat Gas, Cipla among 10 stocks which brokerages have upgraded to 'buy'
Mitesh Thakkar of miteshthakkar.com recommends buying State Bank of India with a stop loss of Rs 320 and target of Rs 335 and Ambuja Cements with a stop loss of Rs 207.5 and target of Rs 222.
Monetary Policy Committee (MPC) of Reserve Bank of India (RBI) has kept the repo rate under the liquidity adjustment facility (LAF) unchanged at 5.15 percent.
Prakash Gaba of prakashgaba.com recommends buying Havells India with target at Rs 645 and stop loss at Rs 623 and IndusInd Bank with target at Rs 1425 and stop loss at Rs 1297.
Ashwani Gujral of ashwanigujral.com recommends buying PVR with a stop loss of Rs 1960, target of Rs 2010 and Kotak Mahindra Bank with a stop loss of Rs 1630, target of Rs 1665.
Mitesh Thakkar of miteshthakkar.com recommends buying ACC with a stop loss of Rs 1533 for target of Rs 1580 and Infosys with a stop loss of Rs 775 for target of Rs 806.
Mitesh Thakkar of miteshthakkar.com recommends buying Bharti Airtel with a stop loss of Rs 461 for target of Rs 485 and GAIL India with a stop loss of Rs 125 for target of Rs 137.
Sudarshan Sukhani of s2analytics.com recommends buying Bosch with stop loss at Rs 15030 and target of Rs 15865 and Bharti Infratel with stop loss at Rs 249 and target of Rs 262.
Shabbir Kayyumi of Narnolia Financial Advisors said a sustained move above 12,000 will push the index higher towards previous highs, starting around 12,100 and can extend towards 12,400
Morgan Stanley also has overweight rating on Lupin with a target price at Rs 1,003, implying 47 percent potential upside from current levels as it believes the share price will rise in absolute terms over the next 30 days.
Deutsche's top picks are Torrent Pharma, Aurobindo Pharma and Cipla which all are buy calls.
Nifty’s 5-week SMA is rising and is placed around 11,611, which implies weakness is only below the crucial support of 11,611
Sudarshan Sukhani of s2analytics.com recommends buying Kotak Mahindra Bank with stop loss at Rs 1355 and target of Rs 1395 and Infosys with stop loss at Rs 732 and target of Rs 745.
The global investment bank is of the view that going forward, the two major events that will give a new direction to the market are Q4FY19 results and the outcome of the central elections.
Mitessh Thakkar of mitesshthakkar.com recommends buying Balkrishna Indistries with a stop loss of Rs 839 and target of Rs 885, Dabur India with a stop loss of Rs 431 and target of Rs 445 and Mahindra & Mahindra with a stop loss of Rs 638 and target of Rs 662.
Mitessh Thakkar of mitesshthakkar.com recommends buying CESC with a stop loss of Rs 716 and target of Rs 755, Cipla with a stop loss of Rs 527 and target of Rs 548 and Hindalco Industries with a stop loss of Rs 207 and target of Rs 219.
Volatility is likely to increase further as we approach Interim Budget, suggest experts and investors should be prepared for sudden movements on either side
The sustainability of RSI above 50 adds the conviction of buying the scrip above Rs 536 for the target of Rs 580 with stop loss of Rs 510 marks.